Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 8, 2011, Pages 1777-1784

  Karpanen, Tarja J ^a   Casey, Anna L ^a   Conway, Barbara R ^b,c   Lambert, Peter A ^b   Elliott, Tom S J ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Antisepsis; Catheter related infections; Ex vivo; Franz diffusion cell

Indexed keywords

CHLORHEXIDINE GLUCONATE; SILICONE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; HYDROGEL DRESSING; IN VITRO STUDY; INOCULATION; INTRAVASCULAR CATHETER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; SERUM; SKIN SURFACE;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BETA-LACTAMASES; CATHETER-RELATED INFECTIONS; CHLORHEXIDINE; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GELS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS;

EID: 79960450644     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr191     Document Type: Article

References (33)

1. Casey AL, Mermel LA, Nightingale P et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 763-76.
2. Pratt RJ, Pellowe CM, Wilson JA et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007; 65 Suppl 1: S1-64.
3. High Impact Intervention No. 1: Central Venous Catheter Care Bundle. http://hcai.dh.gov.uk/files/2011/03/2011-03-14-HII-Central-Venous-Catheter-Care-Bundle-FINAL.pdf (5 May 2011, date last accessed).
4. Pronovost PJ, Goeschel CA, Colantuoni E et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 2010; 340: c309.
5. Sawyer M, Weeks K, Goeschel CA et al. Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections. Crit Care Med 2010; 38: S292-8.
6. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis 1989; 160: 644-50.
7. Hendley JO, Ashe KM. Eradication of resident bacteria of normal human skin by antimicrobial ointment. Antimicrob Agents Chemother 2003; 47: 1988-90.
8. Karpanen TJ, Worthington T, Conway BR et al. Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin. Antimicrob Agents Chemother 2009; 53: 1717-9.
9. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilosebaceous units isolated from human skin. J Gen Microbiol 1984; 130: 803-7.
10. Bashir MH, Olson LK, Walters S. Suppression of regrowth of normal skin flora under chlorhexidine gluconate (CHG) dressings applied to CHG-prepped skin. In: Abstracts of the Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy and the Forty-sixth Meeting of the Infectious Diseases Society of America, Washington, DC, 2008. Abstract K-3-41. American Society for Microbiology, Washington, DC, USA, and Infectious Diseases Society of America, Arlington, VA, USA.
11. Elliott TS, Moss HA, Tebbs SE et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997; 16: 210-3.
12. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intens Care Med 2004; 30: 62-7.
13. Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis 2004; 17: 91-6.
14. Messager S, Hann AC, Goddard PA et al. Use of the 'ex vivo' test to study long-term bacterial survival on human skin and their sensitivity to antisepsis. J Appl Microbiol 2004; 97: 1149-60.
15. Houari A, Di Martino P. Effect of chlorhexidine and benzalkonium chloride on bacterial biofilm formation. Lett Appl Microbiol 2007; 45: 652-6.
16. Knobloch JK, Horstkotte MA, Rohde H et al. Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother 2002; 49: 683-7.
17. Milisavljevic V, Tran LP, Batmalle C et al. Benzyl alcohol and ethanol can enhance the pathogenic potential of clinical Staphylococcus epidermidis strains. Am J Infect Control 2008; 36: 552-8.
18. Hensler JP, Schwab DL, Olson LK et al. Growth inhibition of microorganisms involved in catheter-related infections by an antimicrobial transparent IV dressing containing chlorhexidine gluconate (CHG). In: Abstracts of the Nineteenth European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, 2009. Abstract P-1194. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
19. Maki DG, Stahl J, Jacobson C et al. A novel integrated chlorhexidine-impregnated transparent dressing for prevention of vascular catheter-related bloodstream infection: a prospective comparative study in healthy volunteers. In: Abstracts of the Eighteenth Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Orlando, FL, 2008. Abstract 159. The Society for Healthcare Epidemiology of America, Arlington, VA, USA.
20. Maillard JY, Messager S, Veillon R. Antimicrobial efficacy of biocides tested on skin using an ex-vivo test. J Hosp Infect 1998; 40: 313-23.
21. Messager S, Goddard PA, Dettmar PW et al. Determination of the antibacterial efficacy of several antiseptics tested on skin by an 'ex-vivo' test. J Med Microbiol 2001; 50: 284-92.
22. Messager S, Goddard PA, Dettmar PW et al. Comparison of two in vivo and two ex vivo tests to assess the antibacterial activity of several antiseptics. J Hosp Infect 2004; 58: 115-21.
23. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
24. Adams D, Quayum M, Worthington T et al. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect 2005; 61: 287-90.
25. Dias M, Hadgraft J, Lane ME. Influence of membrane-solvent-solute interactions on solute permeation in model membranes. Int J Pharm 2007; 336: 108-14.
26. Steczko J, Ash SR, Brewer L et al. In vitro and in vivo evaluation of efficacy of citrate/methylene blue/parabens/IPA solution as a skin disinfectant. J Infection 2010; 60: 36-43.
27. Karpanen TJ, Worthington T, Conway BR et al. Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother 2008; 52: 3633-6.
28. Koljalg S, Naaber P, Mikelsaar M. Antibiotic resistance as an indi-cator of bacterial chlorhexidine susceptibility. J Hosp Infect 2002; 51: 106-13.
29. Pitten FA, Werner HP, Kramer A. A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003; 55: 108-15.
30. Kaiser N, Klein D, Karanja P et al. Inactivation of chlorhexidine gluconate on skin by incompatible alcohol hand sanitizing gels. Am J Infect Control 2009; 37: 569-73.
31. Russell AD, Day MJ. Antibacterial activity of chlorhexidine. J Hosp Infect 1993; 25: 229-38.
32. Schwab DL, Olson LK. Antimicrobial activity of a CHG-impregnated gel pad for IV site protection. In: Abstracts of the Infusion Nursing Society Annual Convention and Industrial Exhibition, Orlando, FL, 2008. Infusion Nursing Society, Norwood, MA, USA.
33. Schwab D, Huikko K, Asmus R et al. Migration of chlorhexidine gluconate under antimicrobial gel pad of IV securement dressing to provide continuous antimicrobial protection. In: Abstracts of the Twenty-second Annual Conference of the Association for Vascular Access, Savannah, Georgia, 2008. Association for Vascular Access, Herriman, UT, USA.